Segantii Capital Management’s C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share CXAC.WS Stock Holding History
Bought
Maintained
Sold
Segantii Capital Management's CXAC.WS Position: Q4 2023 in Review
Segantii Capital Management sold out of C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (CXAC.WS) in Q4 2023, closing a stake of 50,000 shares — an estimated $549K sold.
Segantii Capital Management first reported a position in CXAC.WS in Q1 2022 and held it in 7 quarters. The position peaked at $549K in Q3 2023. 0 funds tracked by Wall St. Rank hold CXAC.WS as of Q4 2023.
- Segantii Capital Management reported no remaining C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position as of Q4 2023 after selling out during the quarter.
- Segantii Capital Management sold 50,000 C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share shares in Q4 2023, an estimated $549K.
- Segantii Capital Management first reported a position in C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in Q1 2022 and held it in 7 quarters.
- Segantii Capital Management's C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position peaked at $549K in Q3 2023.
- 0 funds tracked by Wall St. Rank held C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share as of Q4 2023.
Based on Segantii Capital Management's 13F filing for Q4 2023, filed 7 Feb 2024.